A compound in African wormwood shows promise in treating tuberculosis by targeting both active and dormant bacteria. This ...
STOCKHOLM, Sweden, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Calliditas Therapeutics AB (Nasdaq Stockholm: CALTX) ("Calliditas”), ...
Today, the American Lung Association Research Institute announced a $22 million research investment in the past year, making ...
Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, will present new data at IDWeek 2024 focused on ...
While popular media has often portrayed TB, or "consumption" as it was once called, as a disease of pale skin and coughing up ...
A new report by the World Health Organization (WHO) finds that vaccines against 24 pathogens could reduce the number of ... with AMR could be averted annually when new vaccines for tuberculosis (TB) ...
Tuberculosis (TB) is a serious infectious disease caused by the bacterium Mycobacterium tuberculosis, according to the ...
Typically, Nemours treats one to two patients with tuberculosis a year. Four at one time with a drug-resistant form of the ...
Tuberculosis kills 1.5 million people annually and is a top ... To better understand the events within this epicenter of infection, the Gern Lab investigates host-pathogen interactions within the ...